Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of dexmedetomidine and labetalol on blood pressure during maxillofacial fracture surgery
IRCT20170408033291N3Phase 3Completed
- Sponsor
- Qazvin University of Medical Sciences
- Start
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of dexmedetomidine and labetalol in Mandible fracture (2 arms), sponsored by Qazvin University of Medical Sciences. Primary endpoint: Perioperative blood pressure control. Started Dec 2018; status: completed.
02
Drugs
dexmedetomidinelabetalol
03
Conditions
Mandible fracture
Beyond the preview
Go deeper on IRCT20170408033291N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20170408033291N3.